Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.934 EUR | -0.21% | +1.36% | -15.55% |
Apr. 24 | CapMan to Sell Special Transport Group Havator | MT |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Sales 2024 * | 70.3M 75.38M | Sales 2025 * | 79.47M 85.21M | Capitalization | 341M 366M |
---|---|---|---|---|---|
Net income 2024 * | 22M 23.59M | Net income 2025 * | 33M 35.38M | EV / Sales 2024 * | 5.57 x |
Net Debt 2024 * | 50.17M 53.79M | Net Debt 2025 * | 37.83M 40.57M | EV / Sales 2025 * | 4.77 x |
P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
9.85
x | Employees | 200 |
Yield 2024 * |
5.86% | Yield 2025 * |
7.93% | Free-Float | 65.89% |
Latest transcript on CapMan Oyj
1 day | -0.21% | ||
1 week | +1.36% | ||
Current month | -0.10% | ||
1 month | +1.15% | ||
3 months | -13.27% | ||
6 months | -10.67% | ||
Current year | -15.55% |
Managers | Title | Age | Since |
---|---|---|---|
Pia Kåll
CEO | Chief Executive Officer | 44 | 23-03-14 |
Joakim Frimodig
CHM | Chairman | 46 | 15-12-31 |
Atte Rissanen
DFI | Director of Finance/CFO | 37 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
BRD | Director/Board Member | 68 | 21-03-16 |
Director/Board Member | 67 | 19-03-12 | |
Director/Board Member | 58 | 93-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.934 | -0.21% | 157,959 |
24-04-24 | 1.938 | +0.62% | 82,116 |
24-04-23 | 1.926 | +0.73% | 77,449 |
24-04-22 | 1.912 | +0.84% | 52,029 |
24-04-19 | 1.896 | -0.63% | 102,211 |
Delayed Quote Nasdaq Helsinki, April 25, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.55% | 366M | |
-2.64% | 33.98B | |
+1.79% | 31.77B | |
+6.71% | 5.57B | |
-0.21% | 3.11B | |
+12.78% | 2.93B | |
+20.58% | 2.86B | |
-21.28% | 2.24B | |
+4.52% | 1.24B | |
-3.44% | 1.07B |
- Stock Market
- Equities
- CAPMAN Stock